• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 4, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

UCLA Awarded $7.1M Federal Grant to Advance Psychotherapy Treatments for Chronic Pain

Bioengineer by Bioengineer
September 3, 2025
in Health
Reading Time: 5 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A groundbreaking initiative is underway at UCLA Health following the award of a $7.1 million grant from the National Institutes of Health (NIH) aimed at advancing research on emotional awareness and expression therapy (EAET). This innovative form of psychotherapy represents a significant departure from traditional cognitive behavioral therapy (CBT), particularly in its application to chronic pain management. Early clinical evidence suggests that EAET could revolutionize treatment paradigms for older adults battling persistent pain conditions, showcasing effectiveness far beyond what conventional methods have achieved.

EAET, developed in the 2010s, is predicated on the understanding that chronic pain is not merely a physiological phenomenon but intricately tied to the brain’s processing of stress-related emotions. The therapy operates on the premise that pain perception is a neurobiological process influenced at multiple levels by unresolved emotional conflicts and stressors. Unlike classic CBT, which primarily addresses maladaptive thought patterns, EAET facilitates patients in recognizing and processing emotional stressors—ranging from everyday life irritations to profound traumas—aiming to rewire neural circuits that link emotion and pain perception.

The upcoming NIH-funded clinical trial represents one of the most ambitious attempts to validate EAET’s therapeutic potential in a real-world clinical environment. Over the course of five years, this large-scale pragmatic trial will enroll approximately 700 older war veterans across seven geographically diverse U.S. Department of Veterans Affairs centers. These sites will serve as testing grounds to assess both the efficacy and practicality of EAET, with the hope of demonstrating scalability for widespread clinical adoption tailored for the veteran population, a group disproportionately affected by chronic pain syndromes.

Leading the charge is Dr. Brandon Yarns, an assistant professor at UCLA Health’s Department of Psychiatry and Biobehavioral Sciences, whose prior research laid the foundation for this pivotal trial. Notably, Dr. Yarns’ earlier study involving 126 veterans was the first comprehensive clinical investigation of EAET specifically targeting older men within the military demographic. That study revealed that 63% of participants receiving EAET achieved significant reductions in chronic pain, compared to only 17% in those subjected to traditional cognitive behavioral therapy. This stark differential underscores EAET’s transformative potential in reshaping chronic pain interventions.

One of the critical scientific insights underpinning EAET is the recognition of the brain’s plasticity concerning pain pathways. Chronic pain often becomes entrenched as maladaptive neural circuits reinforce pain signals, a process exacerbated by unaddressed psychosocial stressors. EAET leverages therapeutic techniques designed to help patients confront and emotionally process these stressors, facilitating neurocognitive changes that diminish the intensity and persistence of pain signals. This approach moves beyond symptom management towards addressing root causes embedded in the brain’s emotional processing systems.

The study design is meticulously structured to ensure robust and clinically relevant results. The first year of the trial will focus on site preparation, clinician training, and comprehensive interviews with participating veterans to tailor the therapeutic protocol effectively. The four subsequent years will involve administering EAET in practical clinical settings, monitoring patient outcomes, and refining methodologies to optimize treatment delivery. Collecting real-world data on effectiveness, adherence, and patient satisfaction will be crucial for translating research findings into standard care practices.

Veterans constitute a uniquely challenging cohort for chronic pain research due to the elevated exposure to physical injuries and psychological trauma such as combat-related stress and post-traumatic stress disorder (PTSD). EAET’s focus on emotional processing makes it especially suited to address this interplay between psychological trauma and somatic pain experiences. By targeting the affective dimension of pain, the therapy aims to break the vicious cycle where emotional distress amplifies pain perception, subsequently worsening mental health and quality of life.

From a neurobiological perspective, EAET interventions engage brain regions implicated in emotion regulation and pain modulation, including the anterior cingulate cortex, amygdala, and prefrontal cortex. Emerging neuroimaging studies hint at alterations in connectivity and functional activation patterns associated with emotional disclosure and expression, providing empirical support for the therapy’s mechanistic hypotheses. These findings suggest that emotional processing not only serves psychological relief but induces tangible changes in central nervous system activity related to pain experience.

The potential implications of EAET extend far beyond the veteran population. Chronic pain affects a substantial portion of the aging population worldwide, often resistant to pharmacological treatments and burdened by side effects. If this five-year trial corroborates earlier findings, EAET may be integrated into geriatric pain management protocols, offering a non-pharmacological, scalable, and patient-centered approach that addresses the multidimensional nature of chronic pain in older adults.

Moreover, EAET’s emphasis on emotional processing aligns with contemporary shifts in psychological treatment frameworks that advocate for trauma-informed care. By acknowledging and therapeutically targeting the emotional antecedents of pain, EAET offers a paradigm that is congruent with holistic models of health that consider the biopsychosocial dimensions of disease. This approach resonates with broader mental health initiatives aimed at improving functional outcomes and reducing chronic disability.

Despite the promising outlook, several challenges remain as this therapy moves into wider clinical application. Training sufficient numbers of clinicians in EAET’s specialized techniques, ensuring fidelity of implementation, and addressing variability in patient emotional readiness and engagement will be critical factors influencing scalability and effectiveness. The planned clinical trial’s pragmatic design is particularly well-suited to uncovering and addressing these translational hurdles.

In summary, UCLA Health’s new NIH-funded clinical trial embodies a significant leap forward in chronic pain research. By rigorously testing emotional awareness and expression therapy among a large and diverse veteran cohort, the research aims to validate a treatment modality that not only alleviates pain more effectively than traditional cognitive behavioral therapy but also targets its neuropsychological underpinnings. This work stands to fundamentally alter the landscape of chronic pain management, offering hope to millions of older adults wrestling with persistent pain rooted in complex emotional experiences.

The forthcoming results of this comprehensive study will likely generate wide-reaching interest across medical, psychological, and veteran care communities. Success in this arena could catalyze a paradigm shift emphasizing emotional processing as a cornerstone of chronic pain treatment, potentially encompassing other conditions where psychosocial factors play a decisive role. As such, EAET at UCLA Health symbolizes a convergence of cutting-edge neuroscience, innovative psychotherapy, and compassionate clinical care designed to transform how chronic pain is understood and treated in aging populations.

Subject of Research: Emotional awareness and expression therapy (EAET) for chronic pain management in older veterans

Article Title: UCLA Health Launches Landmark NIH-Funded Clinical Trial Exploring Emotional Awareness and Expression Therapy to Alleviate Chronic Pain in Older Veterans

News Publication Date: June 2024

Web References:
– NIH Clinical Trial Details: https://reporter.nih.gov/search/3E6H7MI-JUiMjX3jpWFLiA/project-details/11229006
– Prior Research Publication: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2819961?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=061324

Keywords: Chronic pain, Psychiatry, Emotions, Older adults, War, Warfare

Tags: advanced treatments for older adultschronic pain management innovationscognitive behavioral therapy alternativeseffectiveness of emotional processing in therapyemotional awareness and expression therapyemotional conflicts and painfederal grant for psychotherapyneurobiological pain perceptionNIH clinical trial fundingrevolutionary psychotherapy approachestreatment paradigms for chronic painUCLA Health

Tags: Chronic pain managementEmotional awareness and expression therapyNIH-funded researchPsychotherapy clinical trialVeterans mental health
Share12Tweet7Share2ShareShareShare1

Related Posts

Commensal Yeast Boosts Salmonella Typhimurium Virulence

September 4, 2025

Resilience Boosts Nursing Quality in Kermanshah EDs

September 4, 2025

Enhancing Neurovascularization for Better Bone Regeneration

September 4, 2025

Diet and Inflammation’s Link to Polycystic Ovary Syndrome

September 4, 2025

POPULAR NEWS

  • Needlestick Injury Rates in Nurses and Students in Pakistan

    297 shares
    Share 119 Tweet 74
  • Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    118 shares
    Share 47 Tweet 30

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Renewable Biohydrogen from Cassava Wastewater & Glycerol

Commensal Yeast Boosts Salmonella Typhimurium Virulence

Resilience Boosts Nursing Quality in Kermanshah EDs

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.